Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2460]

Autologous tumour infiltrating lymphocytes cell therapy in metastatic non-small...

Dr Erminia Massarelli - City of Hope, Duarte, USA

Autologous tumour infiltrating lymphocytes cell therapy in metastatic non-small cell lung cancer ( Dr Erminia Massarelli - City of Hope, Duarte, USA )

Incorporating KRAS as a novel biomarker: Challenges and opportunities

Prof Ales Ryska - Charles University, Prague, Czech Republic

Incorporating KRAS as a novel biomarker: Challenges and opportunities ( Prof Ales Ryska - Charles University, Prague, Czech Republic )

Real world data and diagnostics in patients with NSCLC with EGFR exon 20...

Prof Nicolas Girard, Prof Keith Kerr, Prof Frank Griesinger and Dr Antonio...

Real world data and diagnostics in patients with NSCLC with EGFR exon 20 insertions ( Prof Nicolas Girard, Prof Keith Kerr, Prof Frank Griesinger and Dr Antonio Passaro )

Durvalumab following radiotherapy in patients with unresectable, stage 3 NSCLC...

Prof Andrea Filippi - University of Pavia, Pavia, Italy

Durvalumab following radiotherapy in patients with unresectable, stage 3 NSCLC ineligible for chemotherapy ( Prof Andrea Filippi - University of Pavia, Pavia, Italy )

Neo-adjuvant therapy and surgical decision making in breast cancer

Dr Mehra Golshan - Yale School of Medicine, New Haven, USA

Neo-adjuvant therapy and surgical decision making in breast cancer ( Dr Mehra Golshan - Yale School of Medicine, New Haven, USA )

Nurse's perspective on PARP inhibitors and personalised medicine in prostate...

Louisa Fleure - Guy's and St Thomas' NHS Trust, London, UK

Nurse's perspective on PARP inhibitors and personalised medicine in prostate cancer ( Louisa Fleure - Guy's and St Thomas' NHS Trust, London, UK )

COVID-19 pandemic threatens global life-saving gains in childhood cancer

Prof Kathy Pritchard-Jones - University College London, London, UK

COVID-19 pandemic threatens global life-saving gains in childhood cancer ( Prof Kathy Pritchard-Jones - University College London, London, UK )

Emergence of PARP inhibitors in prostate cancer

Kenrick Ng - Senior Specialist Registrar in Medical Oncology, UCL Hospitals...

Emergence of PARP inhibitors in prostate cancer ( Kenrick Ng - Senior Specialist Registrar in Medical Oncology, UCL Hospitals, London, UK )

OncoAlert and ecancer weekly roundup for January 25 - 31, 2021

Dr Gil Morgan - Skåne University Hospital in Lund, Sweden

OncoAlert and ecancer weekly roundup for January 25 - 31, 2021 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )

WCLC 2020: Updates from the CHRYSALIS trial and what it means for patients with...

Dr Joshua Bauml and Dr Joshua Sabari

WCLC 2020: Updates from the CHRYSALIS trial and what it means for patients with NSCLC ( Dr Joshua Bauml and Dr Joshua Sabari )

New data from rare EGFR alterations in NSCLC from WCLC 2020

Prof Tony Mok - Chinese University of Hong Kong, Shatin, Hong Kong

New data from rare EGFR alterations in NSCLC from WCLC 2020 ( Prof Tony Mok - Chinese University of Hong Kong, Shatin, Hong Kong )

A new way of thinking on the origin of breast cancer and how early breast...

Prof László Tabár - University of Uppsala, Uppsala, Sweden

A new way of thinking on the origin of breast cancer and how early breast cancer should be treated ( Prof László Tabár - University of Uppsala, Uppsala, Sweden )

More from ecancer